Vestal Point Capital »

Sanofi-Aventis SA shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Sanofi-Aventis SA (SNY) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Sanofi-Aventis SA

Tip: Access up to 7 years of quarterly data

All positions including Sanofi-Aventis SA held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sanofi-Aventis SA by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.6M 150k 57.63

More positions owned by Vestal Point Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Inari Medical Ord (NARI)
Arcellx Common Stock (ACLX)
Structure Therapeutics Sponsored Ads (GPCR)
Kalvista Pharmaceuticals (KALV)
Astria Therapeutics (ATXS)
Immatics NV SHS (IMTX)
Ultragenyx Pharmaceutical (RARE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Soleno Therapeutics (SLNO)
Day One Biopharmaceuticals I (DAWN)
Savara (SVRA)
Agios Pharmaceuticals (AGIO)

View all positions for Vestal Point Capital

Top funds holding Sanofi-Aventis SA

Dodge & Cox
Fisher Investments
Invesco
Bank of America Corporation
BlackRock
Bank of New York Mellon
FMR
Barrow, Hanley, Mewhinney & Strauss
T. Rowe Price Associates
Wellington Management Company
Goldman Sachs Group
Nuveen Asset Management
Mondrian Investment Partners
Millennium Management
Franklin Resources

View all funds holding Sanofi-Aventis SA